Cited 12 times in
Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.